Article Sidebar

pdf
Date Published: 15/05/2024
Abstract Views: 63
Views pdf: 59
DOI: https://doi.org/10.51298/vmj.v538i3.9640
Issue
Vol. 538 No. 3 (2024)
Section
Các bài báo
How to Cite
Bùi, T. T., Trần, V. G., & Nguyễn, X. H. (2024). CLINICAL AND MICROBIOLOGICAL CHARACTERIZATION IN SEPSIS PATIENTS CAUSED BY AEROMONAS HYDROPHILA AT NATIONAL HOSPITAL FOR TROPICAL DESEASE. Vietnam Medical Journal, 538(3). https://doi.org/10.51298/vmj.v538i3.9640

CLINICAL AND MICROBIOLOGICAL CHARACTERIZATION IN SEPSIS PATIENTS CAUSED BY AEROMONAS HYDROPHILA AT NATIONAL HOSPITAL FOR TROPICAL DESEASE

Thị Thúy Bùi, Văn Giang Trần, Xuân Hùng Nguyễn

Main Article Content

Abstract

Objective: Describe the clinical characteristics and microbiological characterization in patients with septicemia caused by A. hydrophila at National Hospital for Tropical Diseases. Materials and methodes: A cross-sectional study was carried all patients diagnosed with septicemia caused by A. hydrophila at National Hospital for Tropical Diseases during the period from 2011 to 2016. Results: A total of 32 patients with bacteremia due to A. hydrophila were identified. The disease occurs mainly in men (81.3%), patients were hospitalized year-round, but is most common in the rainy and hot months. The most common source of infection is the gastrointestinal tract (71.9%), skin and soft tissues (15.6%). The incidence of septic shock was 37.5%; Shock usually occurs on the 2nd or 3rd day of illness. More than 93% of clinical isolates were susceptible to cephalosporin III antibiotics, fluoroquinolones, aminoglycosides, and carbapenems. Most of isolates were resistant to ampicillin + sulbactam (87.5%), and multi-resistant to both fluoroquinolone and carbapenem (3 - 6%). The mortality were 34.4%.

Article Details

Keywords

Sepsis, A. hydrophila, antimicrobial resistant

References

Tang H. J., Lai C. C., Lin H. L., et al. (2014). Clinical manifestations of bacteremia caused by Aeromonas species in southern Taiwan. PLoS One, 9(3): p. e91642.
2. Dryden M. and Munro R. (1989). Aeromonas septicemia: relationship of species and clinical features. Pathology, 21(2): p. 111-4.
3. Kang J. M., Kim B. N, Choi S. H., et al. (2005). Clinical Features and Prognostic Factors of Aeromonas Bacteremia. IDSA, 37 (Bacterial Diseases): p. 6.
4. Chuang H. C., Ho Y. H., Lay C. J., et al. (2011). Different clinical characteristics among Aeromonas hydrophila, Aeromonas veronii biovar sobria and Aeromonas caviae monomicrobial bacteremia. J Korean Med Sci, 26(11): p. 1415-20.
5. Choi J. P., Lee S. O., Kwon H. H., et al. (2008). Clinical significance of spontaneous Aeromonas bacterial peritonitis in cirrhotic patients: a matched case-control study. Clin Infect Dis, 47(1): p. 66-72..
6. Liu D., Su L., Han G., et al. (2015). Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis. PLoS One, 10(6): p. e0129450.
7. Mat Nor M. B. and Md Ralib A. (2014). Procalcitonin clearance for early prediction of survival in critically ill patients with severe sepsis. Crit Care Res Pract, 2014: p. 819034.
8. Guan J., Lin Z., and Lue H. (2011). Dynamic Change of Procalcitonin, Rather Than Concentration Itself, Is Predictive of Survival in Septic Shock Patients When Beyond 10 ng/mL. Shock, 36(6): p. 4.